SCHEMBL7519203

SCHEMBL7519203

CC(C)c1cc(SC[Si](C)(C)C)c(C(C)C)cc1O

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.37
TRPA1 O75762 1/20 0.35
CHRM1 P11229 1/20 0.35
SLC6A2 P23975 1/20 0.35
ADRA1A P35348 1/20 0.35
HTR2B P41595 1/20 0.35
PKM P14618 1/20 0.33
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
MAPK1 P28482 1/20 0.32
GABRA1 P14867 2/20 0.32
GABRB2 P47870 2/20 0.32
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
HSP90AA1 P07900 5/20 0.31
HSP90AB1 P08238 4/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7520561 0.81 HSP90AA1 (0.37) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL5157681 0.75 LMNA (0.45) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL27565810 0.75 HSP90AA1 (0.39) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL67859 0.72 LMNA (0.58) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL8575083 0.71 CA1 (0.47) LMNASLC6A2HTR2BCYP1A2GABRA1
SCHEMBL8374271 0.69 ALDH1A1 (0.31)
SCHEMBL11144707 0.68 LMNA (0.54) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL13773186 0.68 LMNA (0.54) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL7516559 0.67 CYP1A2 (0.39) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL19334576 0.66 LMNA (0.44) LMNATRPA1CHRM1SLC6A2ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0900225-B1 ALKYL-4-SILYL-PHENOLS AND ESTERS THEREOF AS ANTIATHEROSCLEROTIC AGENTS AVENTIS PHARMA INC (US) 2002-01-30 EP disclosed
US-5608095-A Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents HOECHST MARION ROUSSEL, INC. (US) 1997-03-04 US disclosed